(Q46911481)

26 December 2017

title

Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice (English)

1 reference

26 December 2017

main subject

hepatocellular carcinoma

1 reference

inferred from title

author

Michele T. Yip-Schneider

3

1 reference

26 December 2017

author name string

Sabrina C Wentz

1

1 reference

26 December 2017

Huangbing Wu

2

1 reference

26 December 2017

Matthew Hennig

4

1 reference

26 December 2017

Patrick J Klein

5

1 reference

26 December 2017

Judith Sebolt-Leopold

6

1 reference

26 December 2017

C Max Schmidt

7

1 reference

26 December 2017

publication date

7 November 2007

1 reference

26 December 2017

number of pages

8

1 reference

Journal of Gastrointestinal Surgery

inferred from page(s)

published in

1 reference

26 December 2017

volume

12

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

30-37

1 reference

26 December 2017

Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11605-007-0396-4

Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital

21 January 2018

1 reference

12 December 2020

Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

1 reference

12 December 2020

Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia

1 reference

12 December 2020

Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.

1 reference

12 December 2020

Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor.

1 reference

12 December 2020

Prevention of rat hepatocarcinogenesis by acyclic retinoid is accompanied by reduction in emergence of both TGF-alpha-expressing oval-like cells and activated hepatic stellate cells

1 reference

12 December 2020

Prevention of hepatocellular carcinoma

1 reference

12 December 2020

Prometheus' challenge: molecular, cellular and systemic aspects of liver regeneration.

1 reference

12 December 2020

Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

1 reference

12 December 2020

Increased MAPK expression and activity in primary human hepatocellular carcinoma

1 reference

12 December 2020

Primary liver cancer: worldwide incidence and trends

1 reference

12 December 2020

BRAF mutation predicts sensitivity to MEK inhibition

1 reference

12 December 2020

Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administration

1 reference

12 December 2020

Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.

1 reference

12 December 2020

Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer

1 reference

12 December 2020

Development of liver tumors in transforming growth factor alpha transgenic mice.

1 reference

12 December 2020

Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice

1 reference

12 December 2020

A morphologic classification of proliferative and neoplastic hepatic lesions in mice

1 reference

12 December 2020

Chemoprevention of hepatocellular carcinoma: use of tamoxifen in an animal model of hepatocarcinogenesis

1 reference

12 December 2020

Targeting the mitogen-activated protein kinase cascade to treat cancer

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C.

1 reference

12 December 2020

Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor expression via activation of nuclear factor- B

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study

1 reference

12 December 2020

Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma.

1 reference

12 December 2020

Significance of sequential cellular changes inside and outside foci of altered hepatocytes during hepatocarcinogenesis

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.

1 reference

12 December 2020

Hepatitis B virus infection: epidemiology and vaccination

1 reference

12 December 2020

Significance of hepatic preneoplasia for cancer chemoprevention

1 reference

12 December 2020

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis

1 reference

12 December 2020

Significance of hepatic preneoplasia in risk identification and early detection of neoplasia

1 reference

12 December 2020

10.1007/S11605-007-0396-4

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017